Search

Alan D Cardin

from Cincinnati, OH
Age ~75

Alan Cardin Phones & Addresses

  • 9903 Huntersrun Ln, Cincinnati, OH 45242 (513) 791-9993
  • Oxford, OH
  • Louisville, KY
  • Hamilton, OH
  • 9903 Huntersrun Ln, Cincinnati, OH 45242

Resumes

Resumes

Alan Cardin Photo 1

Alan Cardin

View page
Location:
Cincinnati, OH
Industry:
Pharmaceuticals
Work:
Heptone
Retired
Alan Cardin Photo 2

Director Of Facilities Management

View page
Work:
Georgia Dept of Behavioral Health and Developmental Disabilities
Director of Facilities Management
Alan Cardin Photo 3

Vice President

View page
Location:
Cincinnati, OH
Industry:
Pharmaceuticals
Work:
Abraxisbioscience
Vice President

Business Records

Name / Title
Company / Classification
Phones & Addresses
Alan Cardin
Executive Of Sales
Celsus Laboratories, Inc
Mfg Chemical Preparations · All Other Misc Mfg · Nonclassified Establishments
12150 Best Pl, Cincinnati, OH 45241
(513) 772-8130, (513) 772-8132, (800) 437-2746, (513) 671-1997

Publications

Us Patents

Targeted Agents Useful For Diagnostic And Therapeutic Applications

View page
US Patent:
6409987, Jun 25, 2002
Filed:
Apr 6, 2000
Appl. No.:
09/544266
Inventors:
Alan D. Cardin - Cincinnati OH
Cornelius L. Van Gorp - Springboro OH
Assignee:
Intimax Corporation - Cincinnati OH
International Classification:
A61K 5100
US Classification:
424 173, 424 111, 424 165, 424 91, 534 14
Abstract:
A selectively targeted agent comprising a dermatan sulfate having more than about 25% repeating L-iduronic acidâ4,6-di-O-sulfated N-acetyl-D-galactosamine disaccharide units that is covalently attached or bonded to a radioactive metal-ion binding moiety. The targeted agent is useful in preparing radiagnostic and/or radiopharmaceutical agents for diagnostic and/or therapeutic treatment when combined with an appropriate radioactive metal ion such as Tc, Re or Re.

Combinations Of Heparin Cofactor Ii Agonist And Platelet Iib/Iiia Antagonist, And Uses Thereof

View page
US Patent:
6518244, Feb 11, 2003
Filed:
Mar 9, 2001
Appl. No.:
09/802775
Inventors:
Alan D. Cardin - Cincinnati OH
Cornelius L. Van Gorp - Springboro OH
Assignee:
IntimaX Corporation - Cincinnati OH
International Classification:
A61K 3812
US Classification:
514 11, 514 54
Abstract:
Combined use of a heparin cofactor II agonist and a platelet GPIIb/IIIa receptor antagonist to inhibit both platelet aggregation and thrombin generation resulting from disease, injury or responses to wound repairs. The combined use of the heparin cofactor II agonist and the platelet GPIIb/IIIa receptor antagonist can achieve these therapeutic benefits while at the same time minimizing or reducing the risk of hemorrhagic side effects (e. g. , prolonged bleeding), and without causing undesired antigenic responses. Moreover, certain subtherapeutic amounts of the heparin cofactor II agonist with certain subtherapeutic amounts of a platelet GPIIb/IIIa receptor antagonist can, in combination, be therapeutically effective in inhibiting both platelet aggregation and thrombin generation.

Use Of Dermatan Sulfates And/Or Desulfated Heparins To Treat Or Prevent Heparinoid-Induced Autoimmune Responses

View page
US Patent:
7875596, Jan 25, 2011
Filed:
Jan 16, 2008
Appl. No.:
12/014948
Inventors:
Alan D. Cardin - Cincinnati OH, US
Assignee:
Celsus Biopharmaceuticals, Inc. - Cincinnati OH
International Classification:
A61K 31/737
C08B 37/08
C08B 37/10
A61K 31/727
US Classification:
514 56, 514 54, 536 551, 536123, 5361231
Abstract:
Dermatan sulfates and/or O-desulfated heparins useful in treating and preventing heparinoid-induced autoimmune responses, in particular heparin-induced thrombocytopenia (HIT) and its associated disease states. The dermatan sulfates comprise repeating disulfated and/or trisulfated disaccharide units of L-iduronic acid and N-acetyl-D-galactosamine. The O-desulfated heparins comprise heparin molecules selectively O-desulfated at the 2-O and/or 3-O positions of the uronic acid and glucosamine saccharide residues. Particularly effective dermatan sulfate HIT antagonists have a mean molecular weight of from about 2000 to about 10,000 Daltons.

Use Of Dermatan Sulfates And/Or Desulfated Heparins To Treat Or Prevent Heparinoid-Induced Autoimmune Responses

View page
US Patent:
20050261241, Nov 24, 2005
Filed:
May 19, 2005
Appl. No.:
11/132317
Inventors:
Alan Cardin - Cincinnati OH, US
Assignee:
Celsus Biopharmaceuticals, Inc. - Cincinnati OH
International Classification:
A61K031/737
US Classification:
514054000
Abstract:
Dermatan sulfates and/or O-desulfated heparins useful in treating and preventing heparinoid-induced autoimmune responses, in particular heparin-induced thrombocytopenia (HIT) and its associated disease states. The dermatan sulfates comprise repeating disulfated and/or trisulfated disaccharide units of L-iduronic acid and N-acetyl-D-galactosamine. The O-desulfated heparins comprise heparin molecules selectively O-desulfated at the 2-O and/or 3-O positions of the uronic acid and glucosamine saccharide residues. Particularly effective dermatan sulfate HIT antagonists have a mean molecular weight of from about 2000 to about 10,000 Daltons.

Sulfonic Stilbene Compounds In The Treatment Of Viral Diseases

View page
US Patent:
59326140, Aug 3, 1999
Filed:
Nov 5, 1996
Appl. No.:
8/740905
Inventors:
Alan D. Cardin - Cincinnati OH
A. Stanley Tyms - London, GB
Assignee:
Merrell Pharmaceuticals Inc. - Cincinnati OH
International Classification:
A61K 3116
A61K 31255
A61K 3126
A61K 31275
US Classification:
514514
Abstract:
Sulfonic acid stilbenes block the infection of cells by HIV and these compounds can be used to prevent viral infection.

Narrow Poly- And Mono-Dispersed Anionic Oligomers

View page
US Patent:
59860448, Nov 16, 1999
Filed:
Nov 26, 1997
Appl. No.:
8/979085
Inventors:
Alan D. Cardin - Cincinnati OH
Michael J. Mullins - Midland MI
William A. Fordyce - Midland MI
Thomas A. Chamberlin - Midland MI
Michael J. Fazio - Midland MI
Assignee:
The Dow Chemical Co. - Midland MI
Merrell Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
C09G 7102
A61K 3117
A61K 31795
A01N 3300
US Classification:
528367
Abstract:
The narrow poly- or mono-dispersed oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a recurring unit of from 3 to 50. These oligomers are water-soluble, preferably have a rigid backbone, have recurring units coupled by carbonyl linking moieties which have anionic groups, display predominantly linear geometry such that regular spacing between anionic groups exists in an aqueous medium, and are pharmaceutically-acceptable. The narrow poly- or mono-dispersed oligomers are useful for the treatment and/or diagnosis of AIDS and/or ARC or HSV.

Sulfonic Stilbene Derivatives In The Treatment Of Viral Diseases

View page
US Patent:
56726252, Sep 30, 1997
Filed:
Jun 5, 1995
Appl. No.:
8/463582
Inventors:
Alan D. Cardin - Cincinnati OH
A. Stanley Tyms - London, GB2
Assignee:
Merrell Pharmaceuticals Inc. - Cincinnati OH
International Classification:
A61K 31165
A61K 3126
US Classification:
514514
Abstract:
Sulfonic acid stilbenes block the infection of cells by HSV and CMV and these compounds can be used to treat viral infection.

Sulfated Polysaccharide Fractions Having Anti-Hiv Activity

View page
US Patent:
58613838, Jan 19, 1999
Filed:
Sep 4, 1996
Appl. No.:
8/707354
Inventors:
Alan D. Cardin - Cincinnati OH
Richard L. Jackson - Cincinnati OH
Assignee:
Merrell Pharmaceuticals Inc. - Cincinnati OH
International Classification:
A61K 31715
A61K 31725
US Classification:
514 56
Abstract:
Various peptides having affinity for sulfated polysaccharides such as heparin, dextran sulfate and Pentosan polysulfate are bound to resins and used in affinity chromatography to prepare anti-HIV sulfated polysaccharides.
Alan D Cardin from Cincinnati, OH, age ~75 Get Report